A TEAM from Monash Institute of
Pharmaceutical Science has been
granted $1 million from the Bill &
Melinda Gates Foundation to assist
with their inhaled oxytocin project.
The project is designed to help
save 150,000 mothers each year
around the world, by transforming
oxytocin, which is currently a
needle-administered drug given to
mums to prevent postpartum
haemorrhage (or post birth
bleeding), into an inhalable drug.
Postpartum haemorrhage is one
of the largest preventable causes of
deaths of mums in developing
countries, however if successful,
the inhaled oxytocin will make the
drug safer and more affordable and
accessible for women worldwide.
The Phase II funding will help the
team move to clinical trials in
human patients next year.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Nov 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Nov 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.